Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people taking Wegovy notice changes in their feet, from puffiness and cold sensations to general discomfort. These foot-related effects are not listed as common side effects in the Wegovy prescribing information, but they do come up in practice — often linked to broader circulation shifts, fluid changes, or rapid weight loss rather than semaglutide directly. Understanding what is likely, what warrants a call to your GP, and what usually passes on its own is worth knowing before you start. Wegovy is a prescription-only medicine; a prescriber reviews whether it is clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by mimicking GLP-1, a gut hormone that reduces appetite and slows stomach emptying. It does not act directly on the feet or peripheral circulation. Yet foot symptoms crop up in patient reports often enough to deserve a clear explanation.
Cold feet are the most common concern. As the body loses weight rapidly, fat stores that insulate the feet and lower legs shrink, leaving them more exposed to ambient temperature. At the same time, reduced caloric intake can temporarily lower core body temperature slightly, meaning peripheral circulation to the extremities dials back. These effects tend to be most noticeable in the first few months and often ease as the body adjusts. If cold sensations in the feet are bothering you, reading through the detail on why Wegovy users commonly notice cold feet during treatment will give you a fuller picture, including when to flag it, and you can also explore why semaglutide can leave your hands and feet feeling cold for additional context.
Swelling is the other common report. Some patients experience mild dependent oedema (fluid pooling in the feet and ankles, particularly after standing) as the body redistributes fluid during weight loss. This is different from the cardiac or renal oedema a doctor needs to rule out; it is usually soft, symmetrical, and worsens by evening. Gastrointestinal side effects such as nausea, vomiting and diarrhoea, which are well-documented with semaglutide according to NHS guidance on semaglutide, can lead to dehydration, and paradoxically, dehydration can trigger the body to retain fluid, contributing to the puffy sensation.
Not every foot problem on Wegovy has the same cause, and matching the symptom to the likely mechanism helps you decide how quickly to act.
Cold feet that are bilateral, come and go, and began alongside rapid weight loss are almost always explained by the body-composition and temperature shifts described above. They rarely need treatment beyond warmer socks, staying active, and allowing time. In contrast, cold feet paired with colour changes (white, blue or mottled patches), pain at rest, or a clear difference between one foot and the other may point to poor arterial circulation and warrant prompt GP review. That distinction matters especially if you have type 2 diabetes or cardiovascular risk factors, as peripheral artery disease can worsen without obvious warning.
Foot swelling that is symmetrical and soft is rarely urgent. Asymmetric swelling (one foot or ankle noticeably larger than the other) can signal a blood clot (deep vein thrombosis) and needs same-day medical attention. Swelling alongside breathlessness, chest discomfort, or a rapid heart rate is a call-999 situation. How semaglutide affects how you feel day-to-day covers the broader symptom picture if you want context beyond the feet.
Foot pain on Wegovy is less commonly reported. Where it does occur, the most plausible link is mechanical: as weight drops, the distribution of pressure across the foot changes, sometimes revealing biomechanical issues (flat arches, plantar fascia strain) that extra weight had been masking for years. A physiotherapist or podiatrist can help if this becomes a persistent problem.
For the everyday foot discomfort that does not raise any of the red flags above, practical steps help most people get through the first few months.
Cold feet: layer up earlier in the day rather than waiting until bedtime, by the time you notice it under the duvet, the feet are already struggling to rewarm. Short walks every hour or so keep peripheral circulation ticking over. If you are someone who tends to sit at a desk all morning and then notices cold feet before lunch, building in a brief walk at around the same time each day can make a genuine difference.
Mild swelling: elevating the feet above hip height for 20–30 minutes in the evening shifts fluid back towards the core. Compression socks (graduated, 15–20 mmHg) work well for people who stand or sit for long stretches. Staying well hydrated (which also helps manage nausea) supports kidney function and reduces the signal for the body to retain fluid.
GI side effects that are driving dehydration need addressing directly. The Wegovy data sheet covers the full side-effect and storage profile. The NHS recommends reporting any suspected side effects through the Yellow Card scheme, and that applies to new or worsening foot symptoms too if you think they are linked to treatment.
Foot symptoms that do not follow the patterns above (or that are new, worsening, or making daily life difficult) always warrant a conversation with a clinician rather than self-diagnosis.
At nume, every patient has access to clinician-led aftercare seven days a week; you are never left to figure out unusual symptoms on your own. Our prescribers, led by our clinical team, review each patient's progress individually and can advise whether a symptom needs GP input, a dose review, or simply some reassurance. If you have questions before starting, the FAQs cover common concerns, and our contact page gets you to the team directly.
For a broader grounding in semaglutide as a treatment (how it works, what the clinical trials found, and how it compares to other options) the semaglutide overview and the Wegovy treatment page are good starting points. If you are at the stage of exploring whether Wegovy is the right fit for you, the weight-loss treatment overview sets out the full picture.
If you are ready to discuss whether Wegovy is clinically suitable for you, start your free consultation with our prescribers today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.